Skip to content

The Effect of High vs. Low Fluid Volume on Ocular Parameters in Prone Spine Surgery

Effect of Different Fluid Volume on Ocular Parameters in Patients Undergoing Spine Surgery in Prone Position

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03890510
Enrollment
97
Registered
2019-03-26
Start date
2019-05-01
Completion date
2020-09-07
Last updated
2020-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prone Position, Blood Volume, Intraocular Pressure

Keywords

pulse pressure variation, intraocular pressure, optic sheath diameter, spine surgery, prone position

Brief summary

The purpose of this trial is to compare the effect of different fluid volume infusion on ocular parameters in patients undergoing spine surgery in prone position.

Detailed description

In the prone position, the intraocular pressure and optic nerve sheath diameter increase progressively with time as compared with those in the supine position. Excessive fluid infusion may further increase intraocular pressure and optic nerve sheath diameter. Pulse pressure variation (PPV) is a dynamic index which can effectively assess fluid responsiveness during general anesthesia.Therefore,the investigators have designed a study to compare the effect of different fluid volume infusion guided by low and high PPV indices on intraocular pressure and optic nerve sheath of patients undergoing prone spine surgery with general anesthesia. One group of the patients will receive relatively loose fluid infusion (target value of PPV: 6%-9%),while the other group of the patients will receive limited fluid infusion (target value of PPV: 13%-16%).

Interventions

Patients in both groups will receive Ringer's lactate solution continuously during operation with different infusion volume.

PROCEDURESpine surgery under general Anesthesia in the prone position

The surgery, general anesthesia, and the placement of the prone position will be performed according to the standard procedures.

Sponsors

Huashan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

Patients will be randomly assigned to the limited fluid infusion group and the loose fluid infusion group.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Scheduled for elective spine surgery in prone position under general anesthesia * American Society of Anesthesiologists (ASA) physical status I or II * Have signed consent form

Exclusion criteria

* History of eye disease or eye surgery * Pregnancy or breast feeding * Known Allergy to latex or Ringer's lactate solution * Hyperlactacidemia,uncontrolled hypertension, diabetes mellitus, arrhythmia, cardiovascular disease,chronic pulmonary disease, swelling of any body part, abnormal of liver or renal function, anemia, etc. * Body mass index(BMI)\>30 * Expected operation time \>6 hours * Estimated Intraoperative hemorrhage \>1000ml * Taking part in other clinical trials in the last 3 months or at present

Design outcomes

Primary

MeasureTime frameDescription
The change of intraocular pressure10min after anesthesia induction(supine1), 10min after prone position(prone1), 1 hour after the prone position(prone2), 2 hour after the prone position(prone3),at the end of the surgery(prone4), and 10min after return to the supine position(supine2).Intraocular pressure will be measured with a TONO-PEN AVIA handheld tonometer.

Secondary

MeasureTime frameDescription
The change of the optic sheath diameter10min after anesthesia induction(supine1), 10min after prone position(prone1), 1 hour after the prone position(prone2), 2 hour after the prone position(prone3),at the end of the surgery(prone4), and 10min after return to the supine position(supine2).The optic sheath diameter will be measured with a Sonocite Portable Ultrasonic System EDGE.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026